New Key Statistics Module, Z-Score and F-Score
NAS:COYA Key Ratios
| Market Cap $ M | 121.13 |
| Enterprise Value $ M | 138.29 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.45 |
| Price/Sales | 9.30 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 9.00 |
| EPS (TTM) $ | -0.65 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.18 |
| EV-to-EBITDA | -12.21 |
| PEG | -- |
| Shares Outstanding M | 16.71 |
| Net Margin (%) | -111.99 |
| Operating Margin % | -118.84 |
| Pre-tax Margin (%) | -104.41 |
| Quick Ratio | 15.31 |
| Current Ratio | 15.31 |
| ROA % (ttm) | -32.22 |
| ROE % (ttm) | -36.80 |
| ROIC % (ttm) | -626.05 |
| Dividend Yield % | -- |
| Altman Z-Score | 19.72 |
COYA Number of Guru Trades
COYA Volume of Guru Trades
Gurus Latest Trades with NAS:COYA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:COYA is held by these investors
Total 1
Coya Therapeutics Inc Insider Transactions
No Available Data
News about NAS:COYA
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers